Generate a tailored SOP for Dr. Lorraine Gudas. Improve your application with a focused, well-structured draft.
Dr. Lorraine Gudas leads the Gudas Lab at Weill Cornell Medicine, where her research focuses on understanding the roles of normal stem cells in disease processes, particularly in cancer initiation. The Gudas Lab utilizes molecular pharmacological approaches to develop novel drug therapies targeting cancer, diabetes, kidney disease, and heart disease. Located in the vibrant setting of New York City, the lab is dedicated to discovering new functions of nutrients and retinoids in cancer prevention and treatment. The Gudas Lab is composed of an enthusiastic and dynamic team, including students, postdoctoral fellows, and technicians, who work collaboratively to enhance pharmacological research aimed at helping patients live healthier lives. Gudas's major research goal centers on elucidating how differentiation processes are altered during carcinogenesis, with a particular emphasis on the role of stem cells in this transformation.
Gudas Lab, Weill Cornell Medicine • New York, NY
Leading research initiatives focused on cancer initiation and the development of new pharmacological therapies.
Department of Architecture